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Introduction
Emory Long Term Acute Care (LTAC) hospital admits patients from other
hospitals in Georgia for prolonged mechanical ventilation (PMV) weaning. A
multidisciplinary team developed a protocol for PMV weaning which begins
on admission and continues to decannulation. Within this protocol, anxiety
must be assessed and treated in responsive patients. Previous research
suggests that mechanical ventilation induced anxiety can be a contributing
factor to the patient’s inability to be weaned off ventilator support. Emory
LTAC Hospital uses Geodon®, a second-generation antipsychotic, to
reduce anxiety in patients on PMV. The use of Geodon® has significantly
increased ventilator weaning rates. Per the PMV protocol, the patient’s
anxiety score is evaluated on the third day of admission. If the patient has
an anxiety score of 7 or greater, an order for Geodon® 20mg PO, PT or IM
BID is initiated. Other antipsychotics, such as quetiapine, and
benzodiazepines have been used to reduce ventilator associated anxiety,
but the results were not as effective because these medications do not
reduce anxiety as well and take longer to take effect. Research suggests
that anxiety can be a potential barrier in weaning patients off mechanical
ventilation, and with the help of Geodon® there has been better ventilator
weaning rates within our patient population.
Objective:
• One of the biggest barriers to weaning ventilator patients in a long term
acute care hospital is identifying and treating anxiety. This report details
the second case published using Geodon® to assist in reducing anxiety
to assist in weaning a patient off prolonged mechanical ventilation.
• In this case, the use of Geodon® allowed reduction of anxiety that
was prohibiting the patient from weaning in a state of prolonged
mechanical ventilation. This facility has used Geodon® for ten years
as a major advancement in improving PMV patient outcomes and
ventilator weaning rates which promoted the facility receiving The






A 57-year-old African American female presented to an acute care hospital
with chronic hypercapnic respiratory failure with a past medical history of
asthma, chronic obstructive pulmonary disease, diastolic heart failure,
acute kidney failure, obstructive sleep apnea, hypertension, and type 2
diabetes. She was noted to be in hypercapnic respiratory failure and was
initially treated with Bilevel Positive Airway Pressure (BiPAP) therapy and
admitted to the ICU. In the ICU, her respiratory status worsened despite
BiPAP therapy, requiring her to be intubated and placed on mechanical
ventilation. She was unable to wean from the ventilator and was
transferred to Emory LTAC Hospital.
The patient’s anxiety score was assessed using a modified Beck Anxiety
Inventory (BAI) scale.
• Day 3 of hospitalization revealed a score of 8. (Graph1).
- An anxiety score of 7 or greater represents significant anxiety,
requiring the need of ziprasidone 20mg twice daily (Figure1-b).
• On Day 4 the patient received Geodon® 20mg IM twice daily for 3 days
followed by Geodon® 20mg by mouth twice daily for 29 days.
- She weaned off the ventilator on day 5.
• On Day 6, mechanical ventilation was reestablished and therapy
continued with Geodon® 20mg via percutaneous endoscopic
gastronomy (PEG) tube twice daily for 10 days then Geodon® 20mg by
mouth twice daily for 18 days.
During her last course of therapy, she was able to be taken off mechanical
ventilation support permanently. Her anxiety score decreased while being
treated with Geodon® represented by a total score of 3 on day 7 and 2 on
day 15 of hospitalization (graph 1). She did not receive any other anxiety
medications during her hospitalization. After a course of monitoring, the
patient no longer required mechanical ventilation and was discharged to a
rehabilitation center.
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Figure 1: a) Disease Specific Certified in Respiratory Failure. b) The
protocol approved for weaning patients from Prolonged Mechanical
Ventilation at LTAC- Day 1.
Graph 1: Anxiety rating scale results showed a total score of 8 on day 3,
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